NMTC (NeuroOne Medical Technologies) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NMTC NeuroOne Medical Technologies Corp NMTC
34 GF Score
Price $2.43
GF Value $6.49
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies FFO per Share?

FFO per Share only applies to REITs.

NMTC
34GF Score
NeuroOne Medical Technologies Corp NMTC
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is NeuroOne Medical Technologies (NMTC) Overvalued in 2026?

Based on GuruFocus' analysis, NeuroOne Medical Technologies stock appears to be undervalued. The current stock price of $2.43 is trading 62.6% below its estimated GF Value™ of $6.49. GuruFocus considers NeuroOne Medical Technologies to be Possible Value Trap.

Key valuation signals for NMTC:

  • FFO per Share:
  • GF Value™: $6.49 vs. price of $2.43 (62.6% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the NMTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
34GF Score

Get the complete analysis for NMTC

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.43
Price
$6.49
GF Value